FES Rowing for Skeletal Health After SCI (FES-R)

Using Musculoskeletal Models to Assess FES Rowing for Skeletal Health After SCI

Following a complete spinal cord injury (SCI), individuals experience progressive bone loss, especially in the legs, with up to 70% of persons with SCI sustaining a fracture at some point during their lifetime. Fractures following SCI are costly to treat and more than half of patients experience a medical complication, requiring extended hospitalization, resulting in a substantial impact on their quality of life. To reduce the incidence of fractures, more effective rehabilitation strategies to prevent bone loss are needed. The goal of this research is to determine if bone health can be preserved using an indoor rowing exercise program in which the leg muscles are electrically stimulated using several, small surface electrode pads that are placed on the skin on the front and back thigh muscles. An encouraging case study has recently shown remarkable bone preservation in one individual with SCI who participated in an electrical stimulation rowing program, however, whether other individuals with SCI can achieve the same benefit is currently unknown.

Study Overview

• Status: Completed
• Conditions: Spinal Cord Injury
• Intervention / Treatment: Other: Rowing exercise

Detailed Description

In this study the investigators expect to enroll a total of 10 participants with SCI. Five participants will be assigned to a Standard-of-Care (control) group and five participants will be assigned to an FES-rowing intervention group. Group assignment will be partly based on the preference of each potential participant and their willingness to make the necessary time commitment required for participation in a given group, with the added goal, to the extent possible, of matching the two groups for age, gender and time since injury. Only those individuals who have a strong desire to participate in a regular exercise program and who express a willingness to travel to VA Palo Alto the necessary number of times per week to perform FES-rowing will be potential candidates for inclusion in the rowing group.

Bone density measurements for both the Standard-of-Care group and the FES-rowing group will be performed using Dual energy X-ray Absorptiometry (DXA) and peripheral Quantitative Computed Tomography (pQCT). The Standard-of-Care group will undergo no other research procedures.

The muscle conditioning program is accomplished through electrical stimulation of the quadriceps and hamstring muscles using a 4-channel electrical stimulator that applies stimulation using surface electrodes adhered using gel to the skin overlying the quadriceps and hamstrings muscles. The muscle strengthening initially takes place three times per week, sixty minutes per session, progressing up to five sessions per week, for approximately 8 weeks. The muscle strengthening program ensures that subjects have sufficient muscle strength and endurance before they embark on the rowing program. Following the 8-week muscle strengthening program, subjects will begin FES-rowing, with three sessions per week, thirty minutes per session for the following 28 weeks. In the FES-rowing group, the investigators will measure isometric knee extension strength at the start of week 0, and at the end of weeks 12, 24 and 36.

For the rowing group, the investigators will capture 3D kinetics and kinematics in the motion capture laboratory during FES-rowing at the end of weeks 12, 24 and 36. Kinematics during rowing will be collected from fifty passive retro-reflective markers that will be placed on each participant to capture the position and orientation of the 12 interconnected body segments used to represent each subject.

• Study Type: Interventional
• Enrollment (Actual): 9
• Phase: Not Applicable

Contacts and Locations

Study Locations

• United States
  • California
    • Palo Alto, California, United States, 94304-1290
      • VA Palo Alto Health Care System, Palo Alto, CA

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 18 years and older (Adult, Older Adult)
• Accepts Healthy Volunteers: No
• Genders Eligible for Study: All

Description

Inclusion Criteria:

Subjects in the rowing groups:

• male and female SCI outpatients or inpatients
• have a C7 to T12, ASIA-A or ASIA-B, spinal cord injury
• be at least 18 years old
• have their physician's clearance to exercise
• between 3 and 24 months post spinal cord injury*
• minimum passive hip flexion range of motion (ROM) from 20 to 100 deg
• minimum passive knee flexion ROM from 20 to 100 deg
• minimum passive ankle ROM from +10 deg (dorsi-flexion) to -15 deg (plantar-flexion)
• currently use a manual wheelchair
• be able to perform independent and safe transfers to and from their wheelchair *There is no time post injury restriction for subjects in the experience rower group

Subjects in the control group:

• male and female SCI outpatients or inpatients
• have a C5 to T12, ASIA-A or ASIA-B, spinal cord injury
• be at least 18 years old
• between 3 and 24 months post spinal cord injury
• be able to perform safe transfers to and from their wheelchair, either independently or with assistance

Exclusion Criteria:

• pregnant women
• women of childbearing potential not practicing a reliable method of contraception
• women who are post-menopausal
• have mechanical instability of the spine
• resting blood pressure higher than 140/90
• a grade 1 or greater, sacral, gluteal or ischial pressure ulcer
• history of low trauma, lower limb fracture since SCI
• renal disease
• current osteomyelitis
• current thrombosis/hemorrhage
• cancer
• other neurological disease (i.e. stroke, peripheral neuropathy, myopathy)
• any implanted electronic device
• active treatment for epilepsy
• regular use of tobacco
• known coronary artery disease
• family history of sudden cardiac death
• current use of cardioactive medications, e.g., for treatment of congestive heart failure or arrhythmia

• current use of medications that can affect bone density and fracture risk including:

  • bisphosphonates
  • parathyroid hormone (PTH) and PTH analogs
  • androgenic steroids

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Treatment
• Allocation: Non-Randomized
• Interventional Model: Parallel Assignment
• Masking: None (Open Label)

Number of Arms

2

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
No Intervention: Standard of care group; SCI individuals receiving conventional rehab
Experimental: FES-rowing group; Individuals with SCI participating in an FES-rowing program	Other: Rowing exercise; Individuals with SCI will use the rowing exerciser to see if there is a benefit to skeletal health in the lower limbs.

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Bone Mineral Density	Bone mineral density at the distal femur at 0, 16, 29 and 43 weeks measured using peripheral quantitative computed tomography scanning.	0, 16, 29 and 43 weeks

Collaborators and Investigators

• Sponsor: VA Office of Research and Development
• Investigators: Principal Investigator: Gary Beaupre, PhD, VA Palo Alto Health Care System, Palo Alto, CA

Publications and helpful links

General Publications

• Lambach RL, Stafford NE, Kolesar JA, Kiratli BJ, Creasey GH, Gibbons RS, Andrews BJ, Beaupre GS. Bone changes in the lower limbs from participation in an FES rowing exercise program implemented within two years after traumatic spinal cord injury. J Spinal Cord Med. 2020 May;43(3):306-314. doi: 10.1080/10790268.2018.1544879. Epub 2018 Nov 26.

Study record dates

Study Major Dates

• Study Start (Actual): November 1, 2014
• Primary Completion (Actual): December 4, 2018
• Study Completion (Actual): December 4, 2018

Study Registration Dates

• First Submitted: November 27, 2013
• First Submitted That Met QC Criteria: December 5, 2013
• First Posted (Estimate): December 11, 2013

Study Record Updates

• Last Update Posted (Actual): October 25, 2019
• Last Update Submitted That Met QC Criteria: October 3, 2019
• Last Verified: October 1, 2019

More Information

Terms related to this study

• Keywords: Osteoporosis
• Additional Relevant MeSH Terms: Central Nervous System Diseases; Nervous System Diseases; Wounds and Injuries; Trauma, Nervous System; Spinal Cord Diseases; Spinal Cord Injuries
• Other Study ID Numbers: B1410-P; 5I21RX001410-02 (U.S. NIH Grant/Contract)

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: No

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No
• product manufactured in and exported from the U.S.: No